Delivery Date AI technology has received FDA De Novo clearance for its predictive capabilities on delivering babies using ultrasound imaging. The technology provides real-time insights into fetal development and delivery timing, aiding clinical decision-making in pregnancies where traditional dating methods are unreliable.
The Innovative Cancer Medicines (ICM) initiative, a collaboration between CHAI and PICI, has enrolled the first Nigerian patient in a demonstration project using an immunotherapy drug. The goal is to develop sustainable and effective administration of innovative immuno-oncology therapies in low- and middle-income countries.
A recent study published in The Journal of Maternal-Fetal & Neonatal Medicine showcases Ultrasound AI's proprietary technology, which accurately predicts time to delivery using standard ultrasound images. This non-invasive tool has the potential to improve pregnancy outcomes and combat preterm birth.
The 2025 Schmidt Science Fellows will apply their knowledge to new fields, accelerating discoveries and driving breakthroughs. They will work on various problems, including developing smart artificial blood vessels for regrowth and real-time health monitoring.